Last $30.15 USD
Change Today -0.43 / -1.41%
Volume 374.3K
MR On Other Exchanges
Symbol
Exchange
New York
Singapore
Mexico
Frankfurt
As of 4:15 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

mindray medical intl ltd-adr (MR) Snapshot

Open
$30.71
Previous Close
$30.58
Day High
$30.79
Day Low
$30.07
52 Week High
08/12/13 - $43.81
52 Week Low
05/14/14 - $29.94
Market Cap
3.6B
Average Volume 10 Days
553.4K
EPS TTM
$1.83
Shares Outstanding
88.7M
EX-Date
03/12/14
P/E TM
16.5x
Dividend
$0.50
Dividend Yield
1.65%
Current Stock Chart for MINDRAY MEDICAL INTL LTD-ADR (MR)

mindray medical intl ltd-adr (MR) Related Businessweek News

View More BusinessWeek News

mindray medical intl ltd-adr (MR) Details

Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People’s Republic of China.

7,900 Employees
Last Reported Date: 05/5/14
Founded in 1991

mindray medical intl ltd-adr (MR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mindray medical intl ltd-adr (MR) Key Developments

Mindray Medical International Limited Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Full Year 2014; Announces Executive Changes

Mindray Medical International Limited announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, net revenues were $264,771,000 against $242,103,000 a year ago. Operating income was $31.3 million against $39 million a year ago. Income before income taxes and non-controlling interests was $41,461,000 against $45,789,000 a year ago. Net income attributable to the company was $35,638,000 or $0.30 per basic and diluted share against $57,424,000 or $0.48 per diluted share a year ago. Net cash provided by operating activities was $19,666,000 against $42,390,000 a year ago. Capital expenditures were $27,875,000 against $20,042,000 a year ago. Non-GAAP net income attributable to the company was $46,054,000 or $0.39 per basic and diluted share against $64,570,000 or $0.53 per diluted share a year ago. Non-GAAP operating income was $42.3 million against $46.3 million a year ago. EBITDA decreased 7.8% year-over-year to $46.0 million against $49.8 a year ago. Earnings before interest and taxes were $31,754,000 against $37,775,000 a year ago. The company continues to expect its full year 2014 net revenues to grow at least 15% over its full year 2013 net revenues. The company also continues to anticipate its full year 2014 non-GAAP net income to remain at a similar level to its full year 2013 non-GAAP net income. This guidance excludes the tax benefits related to the nationwide key software enterprise status and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary. The company expects its capital expenditure for full year 2014 to be around $160 million. The company announced that Mr. Jie Liu has resigned from his Chief Operating Officer position for personal reasons, effective immediately. Mr. Wang Jianxin, Mindray's Chief Administrative Officer, will now be the Chief Operating Officer and will focus on research and development, China sales and marketing, manufacturing and supply chain management as well as some other operations. In addition, Mr. Minghe Cheng, Mindray's Co-Chief Executive Officer and Chief Strategic Officer, will oversee international sales and marketing and the North America operations, which were part of Mr. Liu's previous responsibilities.

Mindray Medical International Limited to Report Q1, 2014 Results on May 05, 2014

Mindray Medical International Limited announced that they will report Q1, 2014 results at 5:00 PM, China Standard Time on May 05, 2014

Mindray Medical International Limited, Q1 2014 Earnings Call, May 06, 2014

Mindray Medical International Limited, Q1 2014 Earnings Call, May 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MR:US $30.15 USD -0.43

MR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analogic Corp $74.77 USD -0.21
Hutchinson Technology Inc $2.08 USD -0.02
Masimo Corp $24.41 USD +0.29
OSI Systems Inc $66.09 USD -0.56
Sysmex Corp ¥3,820 JPY +30.00
View Industry Companies
 

Industry Analysis

MR

Industry Average

Valuation MR Industry Range
Price/Earnings 18.0x
Price/Sales 2.9x
Price/Book 2.5x
Price/Cash Flow 17.8x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MINDRAY MEDICAL INTL LTD-ADR, please visit www.mindray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.